Generic Drug Makers Back Away From Health Reform Tab

Kaiser Health News staff writer Phil Galewitz reports on the position generic drug makers have taken regarding how the costs of health reform should be paid. "Generic drug makers — which have saved Americans hundreds of billions of dollars in the past decade with their low-cost, copycat medicines — don't think they should join other health industries to finance a health care overhaul" (10/15).

This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.